Break out session Cancer

Welcome to this years Cancer Breakout Sessions chaired by;
Dr. Klas Wiman (KI), Dr. Theodoros Foukakis (KI), Dr. Dev Mukhopadhyay (MC) and Dr. Andrea Wahner Hendrickson (MC)

8:30 (US CT)/15:30 pm (Sweden)
SESSION 1- Drs. Klas Wiman (KI), Theodoros Foukakis (KI), Dev Mukhopadhyay (MC) and Andrea Wahner Hendrickson (MC)

Welcome – Introduction by the chairs

8:35 am (US CT)/ 15:35 pm (Sweden)
SESSION 2 - Dr. Arne Östman, (KI)

Novel prognosis-associated lung and colon cancer fibroblast subsets

9:00 am (US CT)/ 16:00 pm (Sweden)
SESSION 3- Dr. Derek C. Radisky (MC)

Age-related lobular involution and breast cancer risk prediction

9:25 am (US CT)/ 16:25 pm (Sweden)
SESSION 4 - Dr. Pan Hammarström (KI)

Clinical and genetic characterization of hepatitis B virus-associated B cell lymphoma: insights for novel therapies

9:50 am (US CT)/ 16:50 pm (Sweden)
SESSION 5 - Dr. Baoan Ji (MC)

Genetic PTEN inactivation initiates an extrahepatic cholangitis-cholangiocarcinoma continuum

10:15 am (US CT)/ 17:15 pm (Sweden)
SESSION 6- Abstract Presentation

- John Ovretveit (KI) -- Prostrate cancer: can patient reported outcomes predict deterioration or survival to inform clinical intervention choices? 

- Vasiliki Tsikourkitoudi, (KI)-- Hybrid calcium phosphate nanoplatform for cancer therapy via active targeting 

- Katherine Bolam Enarsson, (KI/Mayo) -- Exercise recommendations for Cancer Patients with Bone Metastases from international expert consensus panel: How they were developed and how to use them.

10:30 am (US CT)/ 17:30 pm (Sweden)
SESSION 6-Adjourned
09:15 am (US CT)/ 16:15 pm (Sweden)
SESSION 1-Dr. Mrinal S Patnaik (MC)

Clonal hematopoiesis of indeterminate potential and associated adverse outcomes.

09:40 am (US CT)/ 16:40 pm (Sweden)
SESSION 2 -Dr. Evanthia Galanis (MC)

Reversing resistance to immune checkpoint inhibitors with oncolytic viruses

10:05 am (US CT)/ 17:05 0pm (Sweden)
SESSION 3- Dr. Fredrik Strand (KI)

Clinical Studies of AI in Breast Imagingnt

10:30 am (US CT)/ 17:30 pm (Sweden)
SESSION 4- Dr. Sonia Lain (KI)

Discovery and anticancer effects of modulators of pyrimidine ribonucleotide metabolism (DHODH inhibitors)

10:55 am (US CT)/ 17:55 pm (Sweden)
SESSION 5-Dr. Johan Hartman (KI)

AI for precision pathology

Asynchronous poster session

Welcome to this years asynchronous poster session within the KI-Mayo Conference 2021. Click here to enter the asynchronous poster session within Cancer.